摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 1-(4-fluorophenyl)-7-chloro-6-nitro-4-oxo-1,4-dihydro-quinoline-3-carboxylate | 148927-35-9

中文名称
——
中文别名
——
英文名称
ethyl 1-(4-fluorophenyl)-7-chloro-6-nitro-4-oxo-1,4-dihydro-quinoline-3-carboxylate
英文别名
Ethyl 7-chloro-1-(4-fluorophenyl)-6-nitro-4-oxoquinoline-3-carboxylate
ethyl 1-(4-fluorophenyl)-7-chloro-6-nitro-4-oxo-1,4-dihydro-quinoline-3-carboxylate化学式
CAS
148927-35-9
化学式
C18H12ClFN2O5
mdl
——
分子量
390.755
InChiKey
WGDWPSAYKGCTJR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    92.4
  • 氢给体数:
    0
  • 氢受体数:
    7

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 6-Aminoquinolones: A New Class of Quinolone Antibacterials?
    作者:Violetta Cecchetti、Sergio Clementi、Gabriele Cruciani、Arnaldo Fravolini、Pier Giuseppe Pagella、Angela Savino、Oriana Tabarrini
    DOI:10.1021/jm00006a017
    日期:1995.3
    acids, designed by previous QSAR studies and characterized by an amino group at the C-6 position instead of the usual fluorine atom, were synthesized for the first time and evaluated for in vitro antibacterial activity. All of the synthesized compounds maintain good activity against Gram-negative bacteria (Pseudomonas aeruginosa excluded), and those compounds having a thiomorpholine group as the C-7 substituent
    通过先前的QSAR研究设计了一系列喹诺酮和1,8-萘啶酮-3-羧酸,它们的特征是在C-6位置的氨基而不是通常的氟原子,并进行了首次体外抗菌活性。所有合成的化合物都对革兰氏阴性菌保持良好的活性(铜绿假单胞菌除外),并且具有硫吗啉基作为C-7取代基的那些化合物也对革兰氏阳性菌具有良好的活性。还讨论了与C-1,C-5,C-7和C-8取代基相关的结构活性关系的某些方面。衍生物18g和38g对革兰氏阴性菌和革兰氏阳性菌分别具有0.45和0.66-0.76微克/ mL的几何平均MIC的最佳活性。这种抗菌活性反映了它们抑制细菌DNA旋转酶的能力。这项研究的结果表明,尽管C-6氟仍然是优选的取代基,但仍可通过用氨基取代而获得良好的活性。
  • Structure Modifications of 6-Aminoquinolones with Potent Anti-HIV Activity
    作者:Oriana Tabarrini、Miguel Stevens、Violetta Cecchetti、Stefano Sabatini、Micaela Dell'Uomo、Giuseppe Manfroni、Manlio Palumbo、Christophe Pannecouque、Erik De Clercq、Arnaldo Fravolini
    DOI:10.1021/jm049721p
    日期:2004.10.1
    We have recently discovered that 6-aminoquinolone derivatives could be valid leads for the development of new anti-HIV agents because of their new and diversified mode of action. In fact, studies carried out on the lead WM5 showed that this derivative is able to inhibit the Tat-mediated long terminal repeat driven transcription, an essential step in the HIV-1 replication cycle. Thus, starting from lead WM5, we performed the design and synthesis of an enlarged series of 6-aminoquinolones, which permitted some very potent anti-HIV 6-amino derivatives to be obtained and the structure-activity relationship to be delineated. Some derivatives, 26c, 26e, 26i, and 26j, proved to be highly effective in inhibiting HIV replication at 50% inhibitory concentration in the range of 0.0087-0.7 mug/mL in MT-4, PBMCs and CEM cell lines coupled with positive selectivity indexes that reach values higher than 1000 on CEM cell lines for compounds 26e and 26i. Time-of-addition experiments clearly confirm that the new, potent 6-aminoquinolones interact at a postintegration step in the replication cycle of HIV.
  • Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids
    作者:Palaniappan Senthilkumar、Murugesan Dinakaran、Perumal Yogeeswari、Dharmarajan Sriram、Arnab China、Valakunja Nagaraja
    DOI:10.1016/j.ejmech.2008.02.031
    日期:2009.1
    Various 1-(substituted)-1,4-dihydro-6-nitro-4-oxo-7-(sub-secondary amino)-quinoline-3-carboxylic acids were synthesized from 2,4-dichlorobenzoic acid by six step synthesis. The compounds were evaluated for antimycobacterial in vitro and in vivo against Mycobacterium tuberculosis H37Rv (MTB), multi-drug resistant Mycobacterium tuberculosis (MDR-TB) and Mycobacterium smegmatis (MC2) and also tested for the ability to inhibit the supercoiling activity of DNA gyrase from M. smegmatis. Among the 48 synthesized compounds, 7-(4-((benzo[d][1,3]dioxol-5-yl)methyl)piperazin-1-yl)-1-cyclopropyl-1,4-dihydro-6-nitro-4-oxoquinotine-3-carboxylic acid (8c) was found to be the most active compound in vitro with MIC of 0.08 and 0.16 mu M against MTB and MDR-TB, respectively. In the in vivo animal model 8c decreased the bacterial load in lung and spleen tissues with 2.78 and 4.15-log 10 protections, respectively, at the dose of 50 mg/kg body weight. (C) 2008 Elsevier Masson SAS. All rights reserved.
  • Synthesis of 1-substituted 6-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylic acids as potential antimicrobial drugs
    作者:R. G. Glushkov、N. B. Marchenko、I. B. Levshin
    DOI:10.1007/bf02464104
    日期:1997.5
查看更多